Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nauclea officinalis extract is a botanical preparation derived from the stems, bark, or leaves of the plant Nauclea officinalis, a member of the Rubiaceae family traditionally used in Chinese medicine. The extracts contain a diverse array of phytochemicals including indole alkaloids (such as strictosamide, naucline, angustine), phenolic acids, pentacyclic triterpenoids, and flavonoids[1][2][3][4][5]. These compounds are associated with multiple pharmacological effects such as anti-inflammatory[9], antibacterial[2], antiviral[2], anti-tumor[2], neuroprotective (notably via cholinesterase inhibition)[7][8], and vasorelaxant activities[4]. Mechanistically, some isolated alkaloids inhibit acetylcholinesterase and butyrylcholinesterase enzymes (AChE/BChE), contributing to neuroprotection and potential cognitive benefits; others demonstrate direct anti-inflammatory or cytotoxic effects on cancer cells. The plant is primarily used for conditions like fever, pneumonia, pharyngolaryngitis (throat inflammation), enteritis (intestinal inflammation), and inflammatory diseases in traditional practice[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nauclea officinalis extract.